ATLAS Market profile
Menu
Atlas ¡ Symbols ¡ ETFs ¡ CDC

Atlas market file ¡ Etf ¡ United States

VictoryShares US EQ Income Enhanced Volatility Wtd ETFCDC

Last close
76.4738
Change
+0.29%
96-bar range
69.65 – 78.48
As of
7 Aug 2026

VictoryShares US EQ Income Enhanced Volatility Wtd ETF is an exchange-traded fund listed as CDC on NASDAQ. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.

Identity
Nasdaq Trader
Chart rail
TradingView
File state
Public profile
Atlas chart snapshot NASDAQ:CDC

Static Daily candlestick snapshot from the approved cache, drawn on a labelled price axis: green bodies closed up, red closed down, wicks span each bar's high-to-low range. The live TradingView link stays available; the public profile never embeds a widget that can render the wrong symbol.

78.744976.40574.06571.725169.385123 Mar01 Jun07 Aug

▮ up candle   ▮ down candle

Latest close76.4738
Day change+0.29%
Window high78.48
Window low69.65
96-bar change+9.09%
SnapshotDaily ¡ 96 bars
As of2026-08-07 13:30 UTC

Weekly outlook: the last 104 weekly closes (+20.98% over the window).

77.33959.5219 Aug07 Aug

Source rail: Yahoo Finance chart API (CDC). This dated snapshot is the crawlable Atlas reference.

Live market viewTradingView ¡ provider feed Open view

Open the attributed TradingView market view for CDC. The dated Atlas snapshot above remains the crawlable reference; exchange data in this panel may be live or delayed as labelled by TradingView.

Loading the attributed market view...

Open full TradingView chart ->

At a glance

CDC public profile

Company

Exchange-traded fund. VictoryShares US EQ Income Enhanced Volatility Wtd ETF is connected to current market context, cited company sources and its retained research file.

Market

VictoryShares US EQ Income Enhanced Volatility Wtd ETF trades as CDC on NASDAQ. VictoryShares US EQ Income Enhanced Volatility Wtd ETF (CDC) has a latest verified close of 76.4738, up 0.29%, dated 7 Aug 2026.

Research

Open the chart, inspect attributed company evidence and continue into the fuller research file without losing this market context. CDC stays in the main symbols index until Atlas has enough listing or name evidence for a narrower browse group.

Institutional Market Wit ● Sourced Research File

For CDC, the ETF wrapper may look like the clever bit, but the basket still has to do the work while the brochure tries to look modest. The story follows CDC through the mandate before the branding gets a voice. A shift in the volatility screen could materially change the portfolio's holdings and income profile, potentially boosting or reducing dividends depending on the new selections. That gives CDC a stronger joke than calling the wrapper clever: the product can speak, but the holdings, rules, fee, liquidity, and exposure still get counted before the label is allowed to look satisfied (source: VictoryShares official ETF centre, https://victoryshares.com/) (source: attached source, https://tools.finra.org/fund_analyzer/; source: attached source...

Unlock 25 custom research runs/day, 104-week candle charts, PDF report downloads & 500-symbol watchlist.

Unlock Atlas Pro — £12/mo Open Free Workstation Run →
Daily answer

What changed for VictoryShares US EQ Income Enhanced Volatility Wtd ETF today

Open full report
CDC daily contextvalidated public digest4 source rail2026-08-07 02:40 UTC

The VictoryShares US EQ Income Enhanced Volatility Wtd ETF, ticker CDC, is a rules-based equity-income wrapper that weights its 110 US holdings by trailing volatility. The fund’s mandate is straightforward: screen the broad US equity universe, select the top third of names by trailing volatility, and then harvest dividends while the volatility screen is in vogue. The issuer markets this as ‘income enhanced by volatility weighting’, but the reality is closer to ‘income plus a fee plus a mechanical tilt’. The fund’s fact sheet does not promise which companies will land in the portfolio next quarter, only that the selection is volatility-weighted. That leaves investors exposed to both the income whims of the screen and the fund’s 0.45% annual charge.

The fund’s top holdings offer a snapshot of this mechanical approach. Recent filings show Verizon Communications Inc. (VZ) perched at the top, followed by names like Nordstrom Inc. (JWN) and Carrier Global Corp. (CARR). The list is a mixed bag of dividend stalwarts and volatility outliers, which means the ‘income enhanced’ label is less a promise and more a rolling outcome of the volatility screen. The issuer’s marketing leans on the theme of volatility-weighted income, but the portfolio itself is a ruleset applied to a broad US equity universe-nothing more, nothing less.

The fund’s prospectus and SEC filings confirm the 0.45% expense ratio and the volatility-weighted selection method. The fund’s page on Nasdaq shows daily volume that can swing from modest to thin, signalling that while the wrapper is open every market day, liquidity is not guaranteed. The SEC EDGAR search confirms the fund’s identity, mandate, and fee structure, but it does not reveal the next quarter’s holdings or the dividend trajectory of the chosen names. The fact sheet promises ‘enhanced income’, yet the only certainty is the fee.

What CDC actually tracks is a quarterly-rebalanced basket of 110 US equities, selected by trailing volatility and then screened for dividend eligibility. The fund’s tracking method is mechanical, not predictive. The issuer’s marketing promises a smoother income ride, but the portfolio is subject to the whims of volatility and the dividend policies of the underlying companies. The fund’s page on Nasdaq provides market data such as volume and price, but it does not offer forward-looking dividend forecasts or volatility projections. The evidence does not include any named earnings releases, revenue figures, or forward guidance for the underlying holdings, which means the fund’s income claims remain a rolling bet on the screen and the market.

The fund’s liquidity profile is visible on Nasdaq, but the daily volume figures are not guaranteed to deepen. The fund’s expense ratio is fixed at 0.45%, and the volatility-weighted selection method is disclosed in filings, but the actual holdings and their dividend outcomes are not predicted by the evidence. The fund’s mandate and fee are clear; the income outcome is not. The issuer’s marketing promises ‘enhanced income’, but the portfolio’s income is a function of the volatility screen and the dividend policies of the underlying companies, neither of which are guaranteed.

Sources & evidence ¡ 4 links

This is the public answer layer. The full Atlas report adds the complete Market Wit archive, risk rail, catalyst map, final editor synthesis, PDF/CSV export, email delivery and saved history.

Ticker
CDC
Exchange
NASDAQ
Sector
Us Public Etf Directory
Region
United States
Asset class
Etf
Directory source
Nasdaq Trader
TradingView

CDC technical readout

Trend strength (ADX 14)
27.7
Average true range (ATR 14)
0.863
ATR as % of price
1.11%
Volatility compression (ATR14/ATR50)
1.21x

Directional bias up. Wilder ADX and ATR computed from Atlas approved daily OHLC through 2026-07-28. Indicators are descriptive statistics, not investment advice.

Source authority

CDC evidence rails

Atlas uses the specific public rails available for CDC: Nasdaq Trader, TradingView, FRED, Atlas methodology. Source names identify the public evidence trail; no partnership, sponsorship or endorsement is implied.

Sources & evidence ¡ 4 rails

Open an Atlas research path on CDC

FreedomCore Atlas can expand this public profile into source-led research files with holdings and concentration, index methodology, exposure and overlap, fees and tracking difference, and liquidity context. Each path keeps the underlying public sources visible.

Open Atlas workstation ->
📄
Institutional Research PDF Available for CDC Verified 104-week candle chart, SEC filing evidence & risk register.
Download PDF
Atlas Pro

Keep CDC research in your Atlas archive

Free Atlas includes the public profile and one owned welcome research artifact after account setup. Atlas Pro adds up to 25 custom research runs a day, a 500-symbol watchlist, saved report versions, and eligible PDF, CSV, and email artifacts. Evidence holds still apply and never become an unverified download. ÂŁ12/month founding price, locked for life. Research only; not investment advice.

Checking Atlas access...

CDC FAQ

What is VictoryShares US EQ Income Enhanced Volatility Wtd ETF (CDC)?VictoryShares US EQ Income Enhanced Volatility Wtd ETF (CDC) has a latest verified close of 76.4738, up 0.29%, dated 7 Aug 2026. Use this page to check the price chart,...

VictoryShares US EQ Income Enhanced Volatility Wtd ETF (CDC) has a latest verified close of 76.4738, up 0.29%, dated 7 Aug 2026. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.

What does Atlas show for CDC?VictoryShares US EQ Income Enhanced Volatility Wtd ETF (CDC) has a latest verified close of 76.4738, up 0.29%, dated 7 Aug 2026. It brings the latest available chart,...

VictoryShares US EQ Income Enhanced Volatility Wtd ETF (CDC) has a latest verified close of 76.4738, up 0.29%, dated 7 Aug 2026. It brings the latest available chart, company context, cited sources, risks and the route into the full Atlas research file together. CDC stays in the main symbols index until Atlas has enough listing or name evidence for a narrower browse group.

How often is the CDC page updated?The CDC public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows the...

The CDC public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows the freshness of the current market snapshot.

Which sources does Atlas use for CDC?The CDC file starts with Nasdaq Trader and TradingView NASDAQ:CDC. The page separates verified market context from company evidence and shows open evidence gaps instead...

The CDC file starts with Nasdaq Trader and TradingView NASDAQ:CDC. The page separates verified market context from company evidence and shows open evidence gaps instead of filling them with assumptions.

Can Atlas run a full research brief on CDC?Yes. The workstation can open CDC, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.

Yes. The workstation can open CDC, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.

Is this CDC page investment advice?No. The CDC page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a promise...

No. The CDC page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a promise of returns.

Methodology

This profile is generated daily from public sources including SEC EDGAR (US-listed companies), NASDAQ Trader files, exchange listings, public macro/central-bank releases, CoinGecko crypto market files where relevant, and the TradingView global symbol catalog. Multi-model AI may assist drafting and review where configured, but sources remain the evidence rail; the chart is an Atlas static OHLC rail with a live TradingView link when verified bars are available; otherwise the page keeps the verified TradingView route as an explicit fallback.

Research only. Not investment advice. No brokerage execution. No guaranteed returns are promised or implied. FreedomCore does not provide personalised investment advice. Always consult a regulated financial advisor before making investment decisions.

Profile last updated: 2026-08-07. Browse FreedomCore Atlas research notes →